Adriana Ochoa

2.3k total citations
62 papers, 1.3k citations indexed

About

Adriana Ochoa is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Adriana Ochoa has authored 62 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cellular and Molecular Neuroscience, 27 papers in Molecular Biology and 18 papers in Neurology. Recurrent topics in Adriana Ochoa's work include Genetic Neurodegenerative Diseases (31 papers), Mitochondrial Function and Pathology (19 papers) and Neurological disorders and treatments (12 papers). Adriana Ochoa is often cited by papers focused on Genetic Neurodegenerative Diseases (31 papers), Mitochondrial Function and Pathology (19 papers) and Neurological disorders and treatments (12 papers). Adriana Ochoa collaborates with scholars based in Mexico, United States and Honduras. Adriana Ochoa's co-authors include Petra Yescas, Astrid Rasmussen, Marie‐Catherine Boll, Ma. Elisa Alonso, Elisa Alonso, María Elisa Alonso, Tetsuo Ashizawa, Aurelio Jara‐Prado, Juan Fernández-Ruíz and Luís Ruano and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Neurology and The American Journal of Human Genetics.

In The Last Decade

Adriana Ochoa

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adriana Ochoa Mexico 20 755 660 400 209 183 62 1.3k
Hélio A.G. Teive Brazil 23 826 1.1× 579 0.9× 771 1.9× 149 0.7× 78 0.4× 120 1.5k
Andre H. Lagrange United States 22 530 0.7× 539 0.8× 126 0.3× 207 1.0× 374 2.0× 50 1.5k
Patrícia de Carvalho Aguiar Brazil 18 573 0.8× 397 0.6× 871 2.2× 82 0.4× 158 0.9× 51 1.4k
Lena E. Hjermind Denmark 18 403 0.5× 405 0.6× 388 1.0× 69 0.3× 98 0.5× 47 904
Kathy Gardner United States 16 378 0.5× 435 0.7× 180 0.5× 259 1.2× 70 0.4× 22 1.1k
Beatrice Paradiso Italy 17 394 0.5× 321 0.5× 95 0.2× 165 0.8× 157 0.9× 36 966
Bassem F. El‐Khodor United States 17 566 0.7× 573 0.9× 176 0.4× 88 0.4× 107 0.6× 26 1.4k
Melodie R. Winawer United States 17 493 0.7× 402 0.6× 294 0.7× 682 3.3× 529 2.9× 36 1.4k
Alessandro Ferraris Italy 21 593 0.8× 422 0.6× 595 1.5× 46 0.2× 203 1.1× 46 1.4k
Mario‐Ubaldo Manto Belgium 14 606 0.8× 332 0.5× 522 1.3× 51 0.2× 81 0.4× 38 1.1k

Countries citing papers authored by Adriana Ochoa

Since Specialization
Citations

This map shows the geographic impact of Adriana Ochoa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriana Ochoa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriana Ochoa more than expected).

Fields of papers citing papers by Adriana Ochoa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriana Ochoa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriana Ochoa. The network helps show where Adriana Ochoa may publish in the future.

Co-authorship network of co-authors of Adriana Ochoa

This figure shows the co-authorship network connecting the top 25 collaborators of Adriana Ochoa. A scholar is included among the top collaborators of Adriana Ochoa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriana Ochoa. Adriana Ochoa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ochoa, Adriana, et al.. (2025). Late-Onset Huntington’s Disease in Mexico: A Retrospective Study. Cureus. 17(10). e94482–e94482.
2.
Rodríguez‐Agudelo, Yaneth, et al.. (2022). Psychological discomfort in carriers and non-carriers of the Huntington disease mutation and its relationship with disease burden. SHILAP Revista de lepidopterología. 40(1). 1–9. 1 indexed citations
3.
Ochoa, Adriana, et al.. (2022). Clinical and Molecular Findings of Intermediate Allele Carriers in the HTT Gene from the Mexican Mestizo Population. Neurodegenerative Diseases. 22(1). 34–42. 3 indexed citations
4.
Valdés‐Flores, Margarita, et al.. (2021). circRNA Regulates Dopaminergic Synapse, MAPK, and Long-term Depression Pathways in Huntington Disease. Molecular Neurobiology. 58(12). 6222–6231. 14 indexed citations
5.
Ochoa, Adriana, et al.. (2021). Ejecución neuropsicológica y carga de enfermedad en sujetos en riesgo de desarrollar enfermedad de Huntington. Neurología. 39(2). 127–134. 1 indexed citations
6.
Hernandez‐Castillo, Carlos R., Rosalinda Díaz, Aurelio Campos‐Romo, et al.. (2019). Extensive cerebellar and thalamic degeneration in spinocerebellar ataxia type 10. Parkinsonism & Related Disorders. 66. 182–188. 17 indexed citations
7.
Ochoa, Adriana, et al.. (2019). Telomere length analysis on leukocytes derived from patients with Huntington Disease. Mechanisms of Ageing and Development. 185. 111189–111189. 13 indexed citations
8.
Ochoa, Adriana, et al.. (2019). Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability. Multiple Sclerosis and Related Disorders. 36. 101386–101386. 56 indexed citations
9.
Hernandez‐Castillo, Carlos R., Roberto E. Mercadillo, Rosalinda Díaz, et al.. (2015). Functional connectivity changes related to cognitive and motor performance in spinocerebellar ataxia type 2. Movement Disorders. 30(10). 1391–1399. 32 indexed citations
10.
García‐Velázquez, Lizbeth, Samuel Canizales‐Quinteros, Sandra Romero‐Hidalgo, et al.. (2013). Founder effect and ancestral origin of the spinocerebellar ataxia type 7 (SCA7) mutation in Mexican families. Neurogenetics. 15(1). 13–17. 11 indexed citations
11.
Jara‐Prado, Aurelio, Iris E. Martínez‐Juárez, Adriana Ochoa, et al.. (2012). Novel Myoclonin1/EFHC1 mutations in Mexican patients with juvenile myoclonic epilepsy. Seizure. 21(7). 550–554. 16 indexed citations
12.
Alonso, María Elisa, Adriana Ochoa, Ana Luisa Sosa, et al.. (2009). Presymptomatic Diagnosis in Huntington's Disease: The Mexican Experience. Genetic Testing and Molecular Biomarkers. 13(6). 717–720. 19 indexed citations
13.
Alonso, María Elisa, Adriana Ochoa, Marie‐Catherine Boll, et al.. (2009). Clinical and genetic characteristics of Mexican Huntington's disease patients. Movement Disorders. 24(13). 2012–2015. 39 indexed citations
14.
Bai, Dongsheng, Julia N. Bailey, Reyna M. Durón, et al.. (2008). DNA variants in coding region of EFHC1: SNPs do not associate with juvenile myoclonic epilepsy. Epilepsia. 50(5). 1184–1190. 11 indexed citations
15.
Alonso, Elisa, Irene De Biase, Christopher C. Mader, et al.. (2007). Distinct distribution of autosomal dominant spinocerebellar ataxia in the Mexican population. Movement Disorders. 22(7). 1050–1053. 37 indexed citations
16.
López, Marisol, Jorge Guerrero, Petra Yescas, et al.. (2007). Apolipoprotein E ε4 allele is associated with Parkinson disease risk in a Mexican Mestizo population. Movement Disorders. 22(3). 417–420. 19 indexed citations
17.
Boll, Marie‐Catherine, et al.. (2005). Use of oral nutritional supplements in patients with Huntington’s disease. Nutrition. 21(9). 889–894. 34 indexed citations
18.
Fernández-Ruíz, Juan, Rosalinda Díaz, Patricia Vergara Aragón, et al.. (2003). Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. Neuroreport. 14(10). 1339–1341. 33 indexed citations
19.
Rasmussen, Astrid, et al.. (2000). Huntington Disease in Children: Genotype-Phenotype Correlation. Neuropediatrics. 31(4). 190–194. 58 indexed citations
20.
Ochoa, Adriana, et al.. (1998). Enfermedad de Huntington. 3(1). 38–46. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026